In the first quarter of 2025, the healthcare company Falck delivered more healthcare services in Europe, the US and Latin America than last year. This resulted in organic revenue growth of 2.5%.
The global healthcare company also continued its strategic investments in digitalisation, operational efficiency and the innovation of new healthcare solutions to strengthen the company for further long-term growth in new and existing markets.
"We delivered in line with our expectations and the increased demand for healthcare services in Scandinavia has helped drive an increase in revenue of 3.3%. The growth confirms that our strategy is gradually expanding our position, and we will continue to back it up with extensive investments,"
says Jakob Riis, CEO of Falck.
Falck has also started preparing for the delivery of an ambulance contract in Catalonia, Spain, which from the beginning of 2026 will increase Falck's position in Spain by 80%.
For the financial year 2025, Falck still expects to achieve organic growth of around 4% and an EBIT margin before special items of 4-5%, despite elevated macroeconomic and geopolitical uncertainty.
Financial highlights
- Revenue amounted to DKK 3,157 million compared with DKK 3,055 million in the same quarter last year
- Operating profit (EBIT before special items) was DKK 121 million compared with DKK 130 million last year
- Profit for the period was DKK 29 million compared with DKK 28 million last year
- Free cash flow after tax was DKK 282 million compared with DKK 141 million last year
DKK million (Falck total)
|
Q1 2025
|
Q1 2024
|
2024
|
Revenue
|
3,157
|
3,055
|
12,134
|
EBIT before special items
|
121
|
130
|
533
|
EBIT margin before special items (%)
|
3.8
|
4.3
|
4.4
|
Profit for the period
|
29
|
28
|
116
|
Free cash flow after tax
|
282
|
141
|
231
|
Revenue growth, % (Falck total)
|
Q1 2025
|
Organic (%)
|
2.5
|
Acquisitions and divestments (%)
|
0.3
|
Exchange rates (%)
|
0.5
|
Reported growth (%)
|
3.3
|
Falck's quarterly report can be found on falck.com